Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
NCSC Cyber Series
Similar topics: blindness
Science
Foundation Fighting Blindness
by Foundation Fighting Blindness
Claiming needs an RSS feed. Contact us.
Recently ranked · United States
Last recorded placements from this show’s chart history. These are not current rankings.
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Foundation Fighting Blindness, try…
Stanford Medcast: Expert Voices in Medicine and Healthcare
Also in Science
Anyway, I Have ADHD
Also in Science
Historical Blindness
Also in Science
Adult Child
Also in Science
We Were Fighting Before This
Also in Science
Ranking history · United States
No ranking history for this show in United States over the last 14 days.
Latest episodes
-
Emerging gene therapy for RDH12-associated Leber congenital amaurosis cleared for clinical trials
October 23, 2026 · 2 minAn emerging gene therapy treatment for Leber congenital amaurosis (LCA) received the green light from the U.S. Food and Drug Administration to proceed with clinical trials in people, bringing it one step closer to patients with a rare form…
-
Eye on the Cure | Episode 104: Dr. Daniel Chung – Emerging XLRP gene therapy shows promising results
October 21, 2026 · 38 minHost Maddie Mossman talks with Dr. Daniel Chung, Chief Medical Officer of Beacon Therapeutics, about Laru-zova, an emerging treatment for X-linked retinitis pigmentosa. Based on encouraging clinical trial results, Beacon plans to begin a…
-
PRPH2 Workshop 2026: Day 1 Keynote – John Samuel
October 5, 2026 · 33 minPRPH2 Workshop 2026: Day 1 Keynote – John Samuel by Foundation Fighting Blindness
-
Early clinical trial results show vision gains in patients with BEST1-related disease
October 2, 2026 · 4 minOpus Genetics has shared encouraging early results from its ongoing Phase 1/2 clinical trial for OPGx-BEST1, a potential one-time gene therapy for people with BEST1-related retinal disease. All five patients enrolled in the clinical trial…
-
Beacon's emerging XLRP gene therapy improves low-light vision in phase 3 trial
September 22, 2026 · 4 minBeacon Therapeutics reported positive results from the Phase 3 pivotal trial of laru-zova, its potential gene therapy treatment for X-linked retinitis pigmentosa. A significant proportion of patients improved dim-light vision by 15 or more…
Show 7 more episodesShow fewer episodes
-
Nanoscope’s investigational RP treatment MOGENRY advances toward FDA approval
September 18, 2026 · 5 minThe U.S. Food and Drug Administration accepted Dallas-based Nanoscope Therapeutics' biologics license application for MOGENRY, an emerging treatment for adults with retinitis pigmentosa and severe vision loss. The investigational treatment…
-
Eye on the Cure Podcast | Episode 103: Kenyetta McCurdy-Byrd and Heather Edwards
September 2, 2026 · 50 minTwo non-profit professionals talk about plugging into community and finding low-vision resources through the Foundation
-
First patient treated with potential retinitis pigmentosa treatment from Sumitomo Pharma America
August 27, 2026 · 2 minSumitomo Pharma America treated its first patient in a Phase 1/2a clinical trial for an emerging retinitis pigmentosa (RP) treatment called DSP-3077. The clinical trial plans to treat 12 adults with one of two different doses to evaluate…
-
Tarsus plans to purchase Alkeus, developer of emerging Stargardt treatment
August 24, 2026 · 3 minTarsus Pharmaceuticals announced plans to acquire Alkeus Pharmaceuticals, including its emerging oral treatment for Stargardt disease, gildeuretinol (ALK-001), in a deal valued up to $800 million. Stargardt disease is the most common form…
-
PRIMA retinal implant restores sight in patients with geographic atrophy from AMD
August 19, 2026 · 4 minIn Europe, Science Corporation has commercially launched PRIMA, a retinal implant designed to restore central vision in people with geographic atrophy (GA). The treatment has been shown in clinical trials to restore functional central…
-
FDA accepts new drug application, prioritizes review for potential Stargardt treatment
August 14, 2026 · 5 minBelite Bio’s tinlarebant could become the first-ever approved treatment for Stargardt disease
-
Eye on the Cure Podcast | Episode 102: What is Venture Philanthropy?
August 5, 2026 · 30 minDr. Alicia Kemble explains how the Foundation is using venture philanthropy to drive treatments for inherited retinal diseases even closer to the finish line.
About the show
The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.